Abstract
This section provides the theoretical background on metabolic phenoty** and its application to human research. We highlight major determinants of the serum lipid composition and describe the principles of mass spectrometry (MS)-based lipidomics as a tool to uncover sex-related differences. Using healthy young (in their twenties) and aged (in their seventies) participants from the Complete Health cohort, we illustrate the workflow on how MS-based lipid signatures can be translated into biologically and physiologically relevant information.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Medina J, et al. Omic-scale high-throughput quantitative LC–MS/MS approach for circulatory lipid phenoty** in clinical research. Anal Chem. 2023;95:3168–79.
Huynh K, et al. High-throughput plasma lipidomics: detailed map** of the associations with cardiometabolic risk factors. Cell Chem Biol. 2019;26:71–84.e74.
Després J-P. Predicting longevity using metabolomics: a novel tool for precision lifestyle medicine? Nat Rev Cardiol. 2020;17:67–8.
Selby K, et al. Low statin use in adults hospitalized with acute coronary syndrome. Prevent Med. 2015;77:131–6.
Carrard J, et al. Metabolic view on human healthspan: a lipidome-wide association study. Metabolites. 2021;11:287.
Beyene HB, et al. High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: evidence from two large population cohort studies. PLoS Biol. 2020;18:e3000870.
Lange M, et al. AdipoAtlas: a reference lipidome for human white adipose tissue. Cell Rep Med. 2021;2:100407.
Züllig T, Köfeler HC. High resolution mass spectrometry in lipidomics. Mass Spectrom Rev. 2021;40:162–76.
Xue J, Guijas C, Benton HP, Warth B, Siuzdak G. METLIN MS(2) molecular standards database: a broad chemical and biological resource. Nat Methods. 2020;17:953–4.
Wishart DS, et al. HMDB 5.0: the Human Metabolome Database for 2022. Nucl Acids Res. 2022;50:D622–d631.
Kind T, et al. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat Methods. 2013;10:755–8.
Horai H, et al. MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom. 2010;45:703–14.
Tsugawa H, et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 2015;12:523–6.
Tsugawa H, et al. A lipidome atlas in MS-DIAL 4. Nat Biotechnol. 2020;38:1159–63.
Gerl MJ, et al. Machine learning of human plasma lipidomes for obesity estimation in a large population cohort. PLoS Biol. 2019;17:e3000443.
Chapman MJ, et al. LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL. J Lipid Res. 2020;61:911–32.
Takeda H, et al. Lipid profiling of serum and lipoprotein fractions in response to pitavastatin using an animal model of familial hypercholesterolemia. J Proteome Res. 2020;19:1100–8.
Lu J, et al. High-coverage targeted lipidomics reveals novel serum lipid predictors and lipid pathway dysregulation antecedent to type 2 diabetes onset in normoglycemic chinese adults. Diabetes Care. 2019;42:2117–26.
Pino MF, et al. Endurance training remodels skeletal muscle phospholipid composition and increases intrinsic mitochondrial respiration in men with Type 2 diabetes. Physiol Genomics. 2019;51:586–95.
Fikenzer K, Fikenzer S, Laufs U, Werner C. Effects of endurance training on serum lipids. Vascul Pharmacol. 2018;101:9–20.
Chua EC, et al. Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc Natl Acad Sci USA. 2013;110:14468–73.
Gooley JJ. Circadian regulation of lipid metabolism. Proc Nutr Soc. 2016;75:440–50.
Hyötyläinen T, Orešič M. Optimizing the lipidomics workflow for clinical studies—practical considerations. Anal Bioanal Chem. 2015;407:4973–93.
Schielzeth H. Simple means to improve the interpretability of regression coefficients. Methods Ecol Evol. 2010;1:103–13.
Searle SR, Speed FM, Milliken GA. Population marginal means in the linear model: an alternative to least squares means. Am Stat. 1980;34:216–21.
Introduction to SAS. UCLA: Statistical Consulting Group. Accessed September 16, 2020. https://stats.idre.ucla.edu/other/mult-pkg/faq/general/faqhow-do-i-interpret-a-regression-model-when-some-variables-are-log-transformed/.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodologic). 1995;57:289–300.
R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. https://www.R-project.org/
Henglin M, et al. A single visualization technique for displaying multiple metabolite-phenotype associations. Metabolites. 2019;9
Wagner J, et al. Functional aging in health and heart failure: the COmPLETE Study. BMC Cardiovasc Disorders. 2019;19:180.
Wagner J, et al. Functional aging in health and heart failure: the COmPLETE Study. BMC Cardiovasc Disord. 2019;19:180.
Esliger DW, et al. Validation of the GENEA Accelerometer. Med Sci Sports Exer. 2011;43:1085–93.
Dekermanjian JP, Shaddox E, Nandy D, Ghosh D, Kechris K. Mechanism-aware imputation: a two-step approach in handling missing values in metabolomics. BMC Bioinformatics. 2022;23:179.
Wei R, et al. Missing value imputation approach for mass spectrometry-based metabolomics data. Scientific Reports. 2018;8:663.
Bull FC, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54:1451–62.
Gonzalez-Covarrubias V, et al. Lipidomics of familial longevity. Aging Cell. 2013;12:426–34.
Johnson LC, et al. The plasma metabolome as a predictor of biological aging in humans. GeroScience. 2019;41:895–906.
Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European heart journal. 2019;41:111–88.
Miller M, et al. Triglycerides and cardiovascular disease. Circulation. 2011;123:2292–333.
Laaksonen R, et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J. 2016;37:1967–76.
Hilvo M, et al. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Eur Heart J. 2019;41:371–80.
Havulinna AS, et al. Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort. Arteriosc Thromb Vasc Biol. 2016;36:2424–30.
Meeusen JW, et al. Plasma ceramides. Arteriosc Thromb Vasc Biol. 2018;38:1933–9.
Chew WS, et al. Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence. JCI Insight. 2019;5
Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med. 2011;365:1812–23.
Chu SH, et al. Integration of metabolomic and other omics data in population-based study designs: an epidemiological perspective. Metabolites. 2019;9:117.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Salamin, O., Carrard, J., Teav, T., Schmidt-Trucksäss, A., Gallart-Ayala, H., Ivanisevic, J. (2023). A Lipidome-Wide Association Study: Data Processing, Annotation, and Analysis Workflow Using MS-DIAL and R. In: Ivanisevic, J., Giera, M. (eds) A Practical Guide to Metabolomics Applications in Health and Disease. Learning Materials in Biosciences. Springer, Cham. https://doi.org/10.1007/978-3-031-44256-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-44256-8_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-44255-1
Online ISBN: 978-3-031-44256-8
eBook Packages: MedicineMedicine (R0)